Relief Therapeutics Holding SA
SIX:RLF

Watchlist Manager
Relief Therapeutics Holding SA Logo
Relief Therapeutics Holding SA
SIX:RLF
Watchlist
Price: 3.135 CHF 11.17% Market Closed
Market Cap: 44.1m CHF

Intrinsic Value

The intrinsic value of one RLF stock under the Base Case scenario is 73.416 CHF. Compared to the current market price of 3.135 CHF, Relief Therapeutics Holding SA is Undervalued by 96%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RLF Intrinsic Value
73.416 CHF
Undervaluation 96%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare RLF to

Fundamental Analysis

Relief Therapeutics Holding SA
SIX:RLF
CH
Biotechnology
Market Cap
44.1m CHF
IPO
Sep 19, 2011
CH
Biotechnology
Market Cap
44.1m CHF
IPO
Sep 19, 2011
Price
CHffalse
EPS
CHffalse
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RLF?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Relief Therapeutics Holding SA

Current Assets 15.2m
Cash & Short-Term Investments 12.5m
Receivables 1.5m
Other Current Assets 1.2m
Non-Current Assets 32.8m
PP&E 2.1m
Intangibles 30.6m
Other Non-Current Assets 113k
Efficiency

Free Cash Flow Analysis
Relief Therapeutics Holding SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Relief Therapeutics Holding SA

Revenue
4.1m CHF
Cost of Revenue
-1.6m CHF
Gross Profit
2.4m CHF
Operating Expenses
-22.1m CHF
Operating Income
-19.6m CHF
Other Expenses
2.6m CHF
Net Income
-17m CHF
Fundamental Scores

RLF Profitability Score
Profitability Due Diligence

Relief Therapeutics Holding SA's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
Net Margin is Increasing
20/100
Profitability
Score

Relief Therapeutics Holding SA's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

RLF Solvency Score
Solvency Due Diligence

Relief Therapeutics Holding SA's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
68/100
Solvency
Score

Relief Therapeutics Holding SA's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RLF Price Targets Summary
Relief Therapeutics Holding SA

There are no price targets for RLF.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Relief Therapeutics Holding SA
does not pay dividends
Shareholder Yield

Current shareholder yield for RLF is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y